MY-1076
Product Specifications
UNSPSC Description
MY-1076 is an inhibitor of YAP. MY-1076 induces YAP degradation and cell apoptosis. MY-1076 inhibits MGC-803, SGC-7901, HCT-116 and KYSE450 cells proliferation with IC50 s of 0.019, 0.017, 0.020 and 0.044 μM, respectively[1].
Target Antigen
Apoptosis; YAP
Type
Reference compound
Related Pathways
Apoptosis;Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/my-1076.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(/C=C/C1=CC(OC)=C(OC)C(OC)=C1)N(C2=CC(OC)=C(OC)C(OC)=C2)CC3=CC(O)=C(OC)C=C3
Molecular Weight
539.57
References & Citations
[1]Xiang-Jing Fu, et al. Design, synthesis and biological evaluation of N-benzylaryl cinnamide derivatives as tubulin polymerization inhibitors capable of promoting YAP degradation with potent anti-gastric cancer activities, European Journal of Medicinal Chemistry, Volume 262, 2023, 115883.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-155360/MY-1076-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-155360/MY-1076-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
3008262-76-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1439039-01 0.02 mg (E-Coli)
Recombinant Sodalis glossinidius tRNA pseudouridine synthase B (truB)
Ask
View Details MBS1439039-02 0.02 mg (Yeast)
Recombinant Sodalis glossinidius tRNA pseudouridine synthase B (truB)
Ask
View Details 
MBS1439039-03 0.1 mg (E-Coli)
Recombinant Sodalis glossinidius tRNA pseudouridine synthase B (truB)
Ask
View Details 
MBS1439039-04 0.1 mg (Yeast)
Recombinant Sodalis glossinidius tRNA pseudouridine synthase B (truB)
Ask
View Details 
MBS1439039-05 0.02 mg (Baculovirus)
Recombinant Sodalis glossinidius tRNA pseudouridine synthase B (truB)
Ask
View Details